Loading…
Loading…
CRL · NYSE · Healthcare
“When a company's earnings are swimming upstream like a salmon, I'd rather wait for clearer waters before wading in.”
— In the voice of Buffett
Determine what growth rate the market is pricing in. Compare implied growth against historical performance to identify mispricing.
Market Cap
$7.73B
P/E Ratio
-53.57
Forward P/E
—
EPS
$-2.91
PEG Ratio
-1.63
Book Value
$63.85
Dividend Yield
—
Profit Margin
-3.59%
ROE
-4.56%
Use the interactive reverse dcf with pre-loaded data for Charles River Laboratories International Inc. Adjust discount rates, growth assumptions, and projection horizons to model different scenarios.
Pre-loaded inputs for CRL: